Protein levels of apoptosis (caspase-3) and autophagy (BECN1) markers were followed to determine the effect of CM on cell death and survival in ALL upon Dex/Etop treatment [49] (Fig 3). This evidence concerns the gene CASP3 and acute lymphoblastic leukemia.